Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorocresol is a chlorinated phenolic compound with potent disinfectant and antiseptic properties. Chemically known as 4-chloro-3-methylphenol or p-chloro-m-cresol (PCMC), it appears as a pinkish white crystalline solid with a phenolic odor. Chlorocresol is widely used for skin disinfection and wound care and serves as a preservative in creams and other water-containing preparations for external use. It is also an active ingredient in various veterinary medicines for topical, oral, and parenteral administration. Its antimicrobial action stems from its ability to disrupt microbial cell membranes, inhibiting the growth of both gram-positive and gram-negative bacteria as well as fungi[1][5][7]. The compound was first introduced as a bactericide in 1897 by Kalle & Co., following discoveries about the efficacy of substituted phenols[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorocresol.